Etalocib
From Infogalactic: the planetary knowledge core
![]() |
|
Names | |
---|---|
IUPAC name
2-(3-{3-[(5-ethyl-4'-fluoro-2-hydroxybiphenyl-4-yl)oxy]propoxy}-2-propylphenoxy)benzoic acid
|
|
Other names
LY293111
VML 295 |
|
Identifiers | |
161172-51-6 ![]() |
|
ChEMBL | ChEMBL329123 ![]() |
ChemSpider | 154905 ![]() |
2948 | |
Jmol 3D model | Interactive image |
KEGG | D04074 ![]() |
PubChem | 177941 |
UNII | THY6RIW44R ![]() |
|
|
|
|
Properties | |
C33H33FO6 | |
Molar mass | 544.62 g·mol−1 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
Etalocib is a drug under development for the treatment of various types of cancer, for example non-small-cell lung carcinoma[1] and pancreatic cancer. It acts as a leukotriene B4 receptor antagonist and a PPARγ agonist.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>